Inpatients seen within target time falls to 68% in Scotland
Professor Derek Bell of the Royal College of Physicians of Edinburgh spoke out against the worsening figures.
Read More
Author: Anna Smith
EMA gives trastuzumab biosimilar Marketing Authorisation Application
The drug is Prestige’s lead development candidate biosimilar to Roche’s Herceptin.
Read More
FDA approval for Novartis’ Piqray
The FDA approval is based on a Phase III trial, SOLAR-1, in which the combination nearly doubled median progression free survival.
Read More
Theresa May failed to tackle “country’s biggest injustices”, says NHS
Back in 2018 she announced that the NHS was to receive an extra £20 billion a year by 2023.
Read More
Santhera submits MAA to EMA for Puldysa
The company is seeking conditional marketing authorisation (CMA) for patients with DMD who are not using glucocorticoids.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
